NRC Health (NRC): Total Assets
$134.88M
As of 2025-12-31
$136.15M
As of 2026-06-30
+1.1%
3-year compound annual growth
+0.2%
5-year compound annual growth
+0.5%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $134.88M | +1.8% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $132.54M | +8.3% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $122.44M | -6.2% | 2025-03-17, Balance as of period end |
| 2022-12-31 | $130.46M | -17.2% | 2024-02-27, Balance as of period end |
| 2021-12-31 | $157.54M | +18.1% | 2024-02-27, Balance as of period end |
| 2020-12-31 | $133.42M | +20.5% | 2023-03-03, Balance as of period end |
| 2019-12-31 | $110.69M | +2.5% | 2022-03-04, Balance as of period end |
| 2018-12-31 | $108.03M | -15.1% | 2021-03-05, Balance as of period end |
| 2017-12-31 | $127.32M | +5.5% | 2020-03-06, Balance as of period end |
| 2016-12-31 | $120.62M | -5.8% | 2019-03-08, Balance as of period end |
| 2015-12-31 | $128.05M | -1.1% | 2018-03-14, Balance as of period end |
| 2014-12-31 | $129.51M | +16.6% | 2017-03-03, Balance as of period end |
| 2013-12-31 | $111.09M | +11.0% | 2016-03-04, Balance as of period end |
| 2012-12-31 | $100.05M | -0.6% | 2015-03-04, Balance as of period end |
| 2011-12-31 | $100.68M | +5.1% | 2013-03-01, Balance as of period end |
| 2010-12-31 | $95.77M | n/a | 2012-03-01, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| NRC Health (NRC) | 2025-12-31 | $134.88M | +1.8% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $202.51M | -15.4% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $300.91M | -7.6% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $44.58M | +6.9% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $1.98B | -6.0% |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $10.96M | +68.3% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $7.14B | -5.2% |
| Incyte Corp (INCY) | 2025-12-31 | $6.96B | +27.8% |
| Absci Corp (ABSI) | 2025-12-31 | $216.30M | +1.3% |
Compare NRC, MXCT, OABI, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗